Table 3.
Crude and adjusted OR and 95% CI of risk for death for 107 patients with the MERS
| Variables | Final outcome | Crude odds ratio (95% CI) |
p-value | Adjusted odds ratio (95% CI) | p-value | |
|---|---|---|---|---|---|---|
| Death no. (%) | Alive no. (%) | |||||
| Gender | ||||||
| Male | 14 | 66 | 1.2 [0.3–4.0] | 0.747 | 1.5[1.3–1.8]a | 0.003 |
| Female | 4 | 23 | 1.00 | 1.00 | ||
| Age group | ||||||
| 16–30 | 1 | 11 | 1.00 | 1.00 | ||
| 31–60 | 7 | 56 | 1.3[1.1–12.3] | 0.091 | 1.3[1.1–12.2]b | 0.029 |
| 61 and upper | 10 | 22 | 5.0[1.4–7.2] | 4.9[1.5–8.4] | ||
| Comorbidity | ||||||
| Yes | 15 | 49 | 4.0[1.1–15.0] | 0.035 | 4.0[1.9–16.3]c | 0.039 |
| No | 3 | 40 | 1.00 | 1.00 | ||
| Nationality | ||||||
| Others | 4 | 9 | 1.00 | 0.042 | 1.00 | 0.012 |
| Saudi | 14 | 80 | 2.5 [1.6–9.3] | 4.2[1.3–11.4]d | ||
| Exposure to camels | ||||||
| Yes | 11 | 42 | 1.7[1.6–4.9] | 1.05[1.1–3.3]e | 0.015 | |
| No | 7 | 47 | 1.00 | 1.00 | ||
| Camel milk consumption | ||||||
| Yes | 11 | 43 | 1.6[1.5–4.7] | 0.021 | 1.05[1.2–2.8]f | 0.004 |
| No | 7 | 46 | 1.00 | 1.00 | ||
| Exposure to MERS-CoV cases | ||||||
| Yes | 11 | 57 | 1.8[1.3–2.5] | 0.002 | 1.06[1.2–2.0]j | 0.008 |
| No | 7 | 32 | 1.00 | 1.00 | ||
| Health care worker | ||||||
| Yes | 17 | 74 | 3.44[1.4–7.9] | 0.009 | 2. 4[1.2–3.1]h | 0.006 |
| No | 1 | 15 | 1.00 | 1.00 | ||
Note: aAdjusted for age; b,cadjusted for sex; d,e,f,hadjusted for age and sex.